Investor That Backed Moderna Raises $3.6B For AI-driven Biotech Ventures

In a recent development, Flagship Pioneering, the venture capital firm known for backing Moderna (NASDAQ:MRNA) has successfully secured a whopping $3.6 billion in funding.What Happened: Flagship

BenzingaJul 10 09:59 ET

Tempus Surpasses 500 Research Publications

Tempus AI, Inc. (NASDAQ:TEM), a leader in artificial intelligence and precision medicine, has reached a research milestone of over 500 research publications. In the last eight years, Tempus has invested in rigorous

BusinesswireJul 10 09:30 ET

Using AI to advance medical care, TempusAI (TEM.US) is favored by Wall Street banks.

Several Wall Street analysts have expressed positive views on TempusAI, a biotechnology company that applies artificial intelligence (AI) to the field of medical care, and expect it to bring sustained revenue.

Zhitong FinanceJul 10 07:01 ET

Buy This Healthcare Company's Stock Because It's an AI Play, Analysts Say

By Tomi Kilgore Tempus AI uses artificial intelligence to analyze lab results and provide diagnostic services A number of Wall Street analysts on Tuesday made bullish calls on the shares of a newly

MarketWatchJul 9 14:23 ET

Sector Update: Health Care Stocks Rise in Afternoon Trading

Health care stocks were higher Tuesday afternoon, with the NYSE Health Care Index rising 0.1% and the Health Care Select Sector SPDR Fund (XLV) up 0.2%.The iShares Biotechnology ETF (IBB) added 0.6%.

MT NewswiresJul 9 14:04 ET

Tempus AI Initiated at Buy by B of A Securities

Tempus AI Initiated at Buy by B of A

Dow JonesJul 9 13:27 ET